Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
about
Microbiology laboratory and the management of mother-child varicella-zoster virus infectionVaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalDissecting the indirect effects caused by vaccines into the basic elementsReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataVaricella: epidemiological aspects and vaccination coverage in the Veneto Region.Impact of varicella vaccine on varicella-zoster virus dynamicsVaricella and varicella vaccination in South KoreaVaricella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004.Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theSuccesses and challenges in varicella vaccinePerspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Effectiveness of 2 doses of varicella vaccine in children.Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011Concurrent multiple outbreaks of varicella, rubeola, german measles in unvaccinated children of co-educational mount carmel senior secondary school, thakurdwara palampur of northern himachal, IndiaTrends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012.Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based StudyValidity of self-reported varicella disease history in pregnant women attending prenatal clinics.Single-dose varicella vaccine effectiveness in school settings in China.Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college studentsImpact of a routine two-dose varicella vaccination program on varicella epidemiology.Knowledge, attitudes, and practices for diagnosing breakthrough varicella in the outpatient settingTwo-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school studentsPrevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Varicella paediatric hospitalisations in Belgium: a 1-year national surveyNew insights into rotavirus vaccines.Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent AssayVaricella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.Too little of a good thing: a paradox of moderate infection control.Efficacy of varicella (VZV) vaccination: an update for the clinician.Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?Examination of links between herpes zoster incidence and childhood varicella vaccination.Incidence and consequences of varicella in children treated for cancer in Guatemala.Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.Varicella vaccination - the global experience.Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay.
P2860
Q26738745-3EA9A53D-502D-4C23-80F3-7CDCC3E24F37Q26749096-373F5DDF-DC99-4C1E-9338-CCB3A9E42F29Q26799527-EE0D9CDA-5FA0-470E-B859-B9425A02B2BFQ26863614-700A6AE6-E5BE-4783-AB66-8A7A12726955Q33500864-FCA12C2B-8D53-4AEF-B9FB-E486B79FF32AQ33591264-77443CE0-620E-4653-80E7-FC054428DCCAQ33601820-2B0AFE20-80FD-4937-9B2E-419D62748E60Q33759666-E8C1461C-D515-4EDC-81B9-01F6C37FB78CQ34074644-A514E0EC-03E1-48A9-828D-9C9C8D6F3534Q34212799-2306A76E-97F2-4CD3-9B8D-9F411A6C9495Q34416710-063C3B41-7B27-4142-A5AE-67C94E66BF2DQ34683751-4836329C-9DCD-482D-9937-E2166C071C25Q34763888-6F60FFD2-DFAD-4D92-ADCD-E0B357C9A4D0Q34788015-C03D3D98-FDDC-4D4A-BB60-76729B2D718EQ35198642-74C0C380-189E-40C9-ABC0-6A0C30864354Q35628205-2ED9BEF7-1145-4D3C-B4AE-E4386EFD1CA5Q35628229-F78C3F90-2301-4478-ABE8-E861FF34ABA8Q35692355-85B660B8-8BDA-4A1B-96D8-D95C2A0B7BEAQ35836724-7224BBE2-BC80-4AF3-9D44-D06F206543FCQ36161043-1128CF64-D5C9-41D9-9BF6-7347E1B4AD95Q36181383-295AA333-FA64-4CFE-8555-36B52BFF90F0Q36206514-8D39ADA7-D394-4003-AB37-26FFA16DD577Q36290048-8F0B0CB1-1967-456B-BDE9-D9F7A12825A6Q36358276-D346A949-C8DC-4D9C-8293-8B77B28CBDBBQ36369132-6BEF365D-69D2-459F-820B-FDE11BCF1DEBQ36475701-D82BCB52-2643-4747-A3BA-40460A58B966Q36552854-C8C4D9D7-F560-41B9-941A-0DFBD78A6164Q36555118-2912E3B1-5C62-409D-8DC3-2B091B606C7AQ36898125-F466452C-16D6-4957-AEDD-E90DD23C6013Q36951972-5DCCB16C-0AC8-416F-9101-BEAF6723BC76Q37120852-1948393D-C38E-4A2F-B5A9-24DCD6868C77Q37158220-01B6491F-8E82-4ADD-A07E-E5C58C371F66Q37404903-417AA31C-7EA2-4F06-90B0-047EBA08C134Q37660930-6C273144-9524-46B9-A372-46729C2513C1Q38423324-77EAF2C9-D0BE-405D-86FD-1E1D94A5D525Q38847684-7006AD13-7A7F-46F9-83F0-D01454D0B1E1Q39032273-11FB2F2B-FE55-4EF3-BFB5-8B60141FE780Q39394364-0FF3A69A-1BAC-413D-A702-879716B4BF6DQ40056713-9DFD7CF3-787D-474F-8B1C-186BDF071D45Q40540257-219A15A2-9758-4BD1-899C-79FED6E5E8B1
P2860
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@en
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@nl
type
label
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@en
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@nl
prefLabel
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@en
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@nl
P2093
P2860
P356
P1476
Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.
@en
P2093
Aisha O Jumaan
Barbara M Watson
Dalya Guris
Dana Perella
Jane F Seward
John X Zhang
Laurene Mascola
Paul Gargiullo
Rachel Civen
Sandra S Chaves
P2860
P356
10.1086/522156
P407
P478
197 Suppl 2
P577
2008-03-01T00:00:00Z